Rockwell Medical (RMTI)

• Market cap: $32.2M
• 1 day: -3.27%
• 5 days: -8.74%
• 1 month: -12.15%
• 3 months: -42.33%
• 6 months: -53.92%
• Year to date: -57.66%
• 1 year: -48.91%
• 5 years: -95.81%
• 10 years: -99.39%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.

Employees: 244

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

298% more call options, than puts

Call options by funds: $195K | Put options by funds: $49K

5.07% less ownership

Funds ownership: 25.52% [Q4 2024] → 20.45% (-5.07%) [Q1 2025]

13% less funds holding

Funds holding: 53 [Q4 2024] → 46 (-7) [Q1 2025]

47% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 19

53% less capital invested

Capital invested by funds: $16.8M [Q4 2024] → $7.87M (-$8.96M) [Q1 2025]

75% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 8

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $3 219% upside
• Avg. target: $3 219% upside
• High target: $3 219% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Raghuram Selvaraju

219% upside $3

Buy Maintained

24 Mar 2025